Duke Cancer Institute (DCI) - The Preston Robert Tisch Brain Tumor Center

Durham, North Carolina 27702-3624

0 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma

Studies at this site

• Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations — Withdrawn before enrolling